← All trials
NCT05299242
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- May 27, 2022
- Primary completion
- Mar 15, 2023
- Completion date
- May 31, 2023
- First posted
- Mar 28, 2022
- Last posted
- Nov 2, 2022
- Enrollment
- 84
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- University of OxfordLead sponsor
- University of OxfordOverall official - principal investigator
- National Institute for Health Research, United KingdomCollaborator
- 180 Life SciencesCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.